Portal de investigación
LIPERAD. LIPID PEROXIDATION BIOMARKERS FOR THE EARLY AND NON-INVASIVE ALZHEIMER DISEASE DIGNOSIS.
Datos básicos
- Código:
- MS16/00082
- Protocolo:
- MS16/00082
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- 202.500,00 €
- Año de incio:
- 2017
- Año de finalización:
- 2021
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A preliminary study to assess the impact of maternal age on stress-related variables in healthy nulliparous women
Garcia-Blanco, A; (...); Chafer-Pericas, C
Article. 10.1016/j.psyneuen.2017.01.018. 2017
Abnormal emotional processing in maltreated children diagnosed of Complex Posttraumatic Stress Disorder
Berto, Clara; (...); Garcia-Blanco, Ana
Article. 10.1016/j.chiabu.2017.09.020. 2017
Angiotensin II Receptor Blockers Reduce Tau/ASS42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study.
Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo
Article. 10.3390/pharmaceutics15030924. 2023
Anxiety and depressive symptoms, and stress biomarkers in pregnant women after in vitro fertilization: a prospective cohort study
Garcia-Blanco, A; (...); Chafer-Pericas, C
Article. 10.1093/humrep/dey109. 2018
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Prats-Climent, Joan; (...); Marti-Bonmati, Luis
Article. 10.1007/s10916-022-01836-w. 2022
Assessment of apolipoprotein E genotype for ß-amyloid status prediction.
Peña-Bautista C; (...); Chafer-Pericas, Consuelo
Article. 10.2174/1567205019666211223141524. 2021
Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1007/s00415-023-11899-5. 2023
Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.clinbiochem.2019.07.008. 2019
Assessment of Lipid Peroxidation in Alzheimer's Disease Differential Diagnosis and Prognosis.
Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo
Article. 10.3390/antiox11030551. 2022
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer's Disease and Frontotemporal Dementia.
Álvarez-Sánchez L; (...); Cháfer-Pericás C
Article. 10.3390/ijms24021226. 2023
Assessment of Screening Approach in Early and Differential Alzheimer's Disease Diagnosis.
Ferré-González L; (...); Cháfer-Pericás C
Article. 10.3390/antiox10111662. 2021
Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo
Article. 10.1177/13872877241304995. 2024
Author Correction: Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease.
Ferré-González L; (...); Cháfer-Pericás C
Correction. 10.1038/s41598-024-52528-z. 2024
Biomarkers of oxidative stress and inflammation in urine samples of extremely preterm newborns and their association with risk for autism at age 6 months
Munoz, T. Bollain; (...); Pina-Camacho, L.
Meeting Abstract. 10.1192/j.eurpsy.2023.1222. 2023
Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo
Article. 10.1038/s41598-024-51463-3. 2024
Can stress biomarkers predict preterm birth in women with threatened preterm labor?
Garcia-Blanco, A; (...); Vento, M
Article. 10.1016/j.psyneuen.2017.05.021. 2017
Can stress predict delivery date?: Role of chronic and acute stress to the threatened preterm labor as predictors of delivery date
Lorenzo, JB; (...); Gonzalez, PS
Meeting Abstract. 10.1192/j.eurpsy.2021.1619. 2021
Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions.
García-Lluch G; (...); Cháfer-Pericás C
Article. 10.14283/jpad.2024.16. 2024
Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer Disease.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1111/eci.13910. 2022
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/antiox9080649. 2020
Communication deficits and avoidance of angry faces in children with autism spectrum disorder
García-Blanco A; (...); Perea M
Article. 10.1016/j.ridd.2017.02.002. 2017
CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints.
Ramos H; (...); Pardo J
Article. 10.3390/jpm12020207. 2022
Cumulative life stressors and stress response to threatened preterm labour as birth date predictors
Campos-Berga, Laura; (...); Garcia-Blanco, Ana
Article. 10.1007/s00404-021-06251-z. 2021
Defining Alzheimer's Disease through Proteomic CSF Profiling.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1021/acs.jproteome.4c00590. 2024
DHA reduces oxidative stress following hypoxia-ischemia in newborn piglets: a study of lipid peroxidation products in urine and plasma
Huun, MU; (...); Solberg, R
Article. 10.1515/jpm-2016-0334. 2018
Discordant Amyloid Status Diagnosis in Alzheimer's Disease.
García-Vallés L; (...); Cháfer-Pericás C
Article. 10.3390/biomedicines10112880. 2022
Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers
Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms241814151. 2023
Early neurotransmission impairment in non-invasive Alzheimer Disease detection
Pena-Bautista, Carmen; (...); Cháfer-Pericás C
Article. 10.1038/s41598-020-73362-z. 2020
Emotion recognition and baseline cortisol levels relationship in early Alzheimer Disease.
Ferrer-Cairols, I.; (...); Chafer-Pericas, C.
Article. 10.1016/j.biopsycho.2023.108511. 2023
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages.
Peña-Bautista C; (...); Chafer-Pericas, Consuelo
Article. 10.3390/biomedicines9121812. 2021
Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment.
Álvarez-Sánchez L; (...); Pericás CC
Article. 10.2174/011570159X332930240925095423. 2024
Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Review. 10.1016/j.cca.2019.01.021. 2019
Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome
Sendra, L; (...); Alino, SF
Article. 10.3390/nano10061183. 2020
Influence of Statin Potency and Liposolubility on Alzheimer's disease patients: a population-based study.
Garcia-Zamora, Mar; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.phrs.2024.107446. 2024
Inhibitory Control for Emotional and Neutral Scenes in Competition: An Eye-Tracking Study in Bipolar Disorder
Garcia-Blanco, A, Salmeron, L, Perea, M
Article. 10.1016/j.biopsycho.2017.05.006. 2017
Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation.
Baquero, Miguel; (...); Chafer-Pericas, Consuelo
Article. 10.3390/jcm13164735. 2024
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/antiox9050407. 2020
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
Pena-Bautista, Carmen; (...); Cháfer-Pericás C
Article. 10.3390/antiox10071043. 2021
Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.neuint.2019.104519. 2019
Lipid Peroxidation in Neurodegeneration
Editorial Material. 10.3390/antiox10030484. 2021
Lipid peroxidation in neurodegeneration.
Peña-Bautista C; (...); Cháfer-Pericás C
Review. 10.1016/j.cca.2019.07.037. 2019
Lipids as early and minimally invasive biomarkers for Alzheimer disease.
Casas-Fernandez, Esther; (...); Chafer-Pericas, Consuelo
Article. 10.2174/1570159X19666211102150955. 2021
Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.jpba.2019.113088. 2020
Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.
Peña-Bautista C; (...); Ferreira D
Article. 10.3389/fmolb.2023.1193458. 2023
Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients
Pena-Bautista, C.; (...); Chafer-Pericas, C.
Article. 10.1016/j.exger.2019.05.007. 2019
New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers.
Forte, Anabel; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.cca.2024.117842. 2024
New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.
Peña-Bautista C; (...); Chafer-Pericas, C
Article. 10.1038/s41598-019-50837-2. 2019
Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients
Rausell, Dolores; (...); Chafer-Pericas, Consuelo
Review. 10.1038/s41390-018-0202-x. 2019
Non-invasive assessment of oxidative stress in preterm infants.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.freeradbiomed.2019.02.019. 2019
Non-invasive monitoring of saliva can be used to identify oxidative stress biomarkers in preterm and term newborn infants
Solaz-Garcia, Alvaro; (...); Saenz-Gonzalez, Pilar
Article. 10.1111/apa.16073. 2021
Non-invasive monitoring of stress biomarkers in the newborn period.
Peña-Bautista C; (...); Vento M
Article. 10.1016/j.siny.2019.04.002. 2019
Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.
Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo
Article. 10.3233/JAD-215093. 2022
Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Review. 10.2174/1570159X16666180926123722. 2019
Oxidative Damage of DNA as Early Marker of Alzheimer's Disease.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.3390/ijms20246136. 2019
Oxygen and oxidative stress in the perinatal period
Torres-Cuevas, Isabel; (...); Vento, Maximo
Review. 10.1016/j.redox.2017.03.011. 2017
Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.cca.2019.10.023. 2020
Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1111/jnc.15183. 2020
Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection
Pena-Bautista, C; (...); Chafer-Pericas, C
Article. 10.1016/j.freeradbiomed.2018.06.038. 2018
Plasma Lipidomics Approach in Early and Specific Alzheimer's Disease Diagnosis.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/jcm11175030. 2022
Plasma lipidomics in early APP/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?
Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo
Article. 10.1186/s13195-024-01549-x. 2024
Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.jprot.2019.04.008. 2019
Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease
Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo
Review. 10.1016/j.jns.2017.01.020. 2017
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
López-Cuevas R; (...); Cháfer-Pericás C
Article. 10.1016/j.nrl.2020.07.026. 2020
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
Lopez-Cuevas, R; (...); Chafer-Pericas, C
Article. 10.1016/j.nrleng.2020.07.024. 2023
Recent evidence in epigenomics and proteomics biomarkers for early and minimally invasive diagnosis of Alzheimer's and Parkinson's diseases.
Mayo, Sonia; (...); Chafer-Pericas, Consuelo
Review. 10.2174/1570159X19666201223154009. 2020
Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.
Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis
Article. 10.1016/j.bbr.2023.114844. 2024
Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms25105317. 2024
Reliable determination of new lipid peroxidation compounds as potential early Alzheimer Disease biomarkers
Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.talanta.2018.03.002. 2018
Response to letter to the editor: An in-depth look at the relationship between anti-diabetic drugs and Alzheimer's disease.
Garcia-Zamora, Mar; (...); Pardo Albiach, Juan
Letter. 10.1016/j.phrs.2024.107396. 2024
Response to letter to the editor: Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer's disease management.
Garcia-Zamora, Mar; (...); Pardo, Juan
Letter. 10.1016/j.phrs.2025.107595. 2025
Response to the comment on "Can stress biomarkers predict preterm birth in women with threatened preterm labor?"
Garcia-Blanco, A; (...); Vento, M
Letter. 10.1016/j.psyneuen.2017.07.490. 2017
Stress and neurodegeneration.
Peña-Bautista C; (...); Cháfer-Pericás C
Review. 10.1016/j.cca.2020.01.019. 2020
Study of the pathophysiological mechanisms associated with the onset and course of neurodevelopmental disorders in preterm infants (the PeriSTRESS-PremTEA study): Rationale, objectives, design and sample description.
Navalón P; (...); García-Blanco A
Article. 10.1016/j.rpsm.2021.02.002. 2021
Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models.
Ferre-Gonzalez, Laura, Lloret, Ana, Chafer-Pericas, Consuelo
Article. 10.1016/j.plipres.2023.101223. 2023
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
Trajectories of stress biomarkers and anxious-depressive symptoms from pregnancy to postpartum period in women with a trauma history
Ghosn, F; (...); Blanco, AG
Article. 10.1080/20008198.2019.1601990. 2019
Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers.
Peña-Bautista C; (...); Cháfer-Pericás C
Article. 10.1016/j.jpba.2018.11.043. 2019